Aim: The number of therapies with radiopharmaceuticals labelled with 188Re is increasing requiring the documentation of the beta radiation exposure Hp(0.07) of the staff at all working and production sites and during the application and follow-up of the patient according to the new German Radiation Protection Law (StrlSchV)...
Keywords: Strahlenschutz, Hautdosis, Beta-Dosimetrie, 188Re-Therapie
01/2005 | Nuklearmedizin, Schattauer